Man Dies After Going to Turkey for a Hair Transplant at a Clinic Frequented by Celebrity Clients
British man Martyn Latchman, 38, died after he underwent a hair transplant procedure in Turkey
Latchman from Milton Keynes, England, died in July after he became ill 'for reasons that are still unknown' as he was being prepped for surgery, the Dr. Cinik clinic in Istanbul said
Turkish health authorities are investigating, and an autopsy will be conductedA British man has died after he underwent a hair transplant procedure in Turkey.
Martyn Latchman, 38, from Milton Keynes, England, died in late July after he became ill during the preparatory phase of his procedure, according to reports from The Independent and the The Guardian.
Latchman traveled to Istanbul to be treated at the Dr. Cinik clinic, and The Independent reported that the medical facility said in a statement that he "unexpectedly became unwell for reasons that are still unknown" as he was preparing for surgery "before the hair transplant procedure had begun."
He was taken to an intensive care unit at a local hospital but died.
Latchman had previously undergone a successful first procedure, and it was his second surgery at the at the clinic, according to The Independent.
Latchman's body has since been transported to the U.K. The local Turkish outlet OdaTV reported that health authorities are investigating, and an autopsy will be conducted, per The Independent.
"All relevant medical documentation related to this incident has been submitted to the appropriate authorities, and the matter is currently being investigated by judicial bodies," the clinic added in its statement. "Due to the ongoing legal process and out of respect for the family's privacy, no further details will be disclosed at this time."
The clinic added that it was "deeply saddened" by Latchman's death, per The Guardian.
A spokesperson for the Foreign Office also told the outlets in a statement: "We are supporting the family of a British man who died in Turkey and are in contact with the local authorities."
Latchman previously worked as a headteacher in Bedford, England, for more than 16 years before switching careers to become a defense contractor last year, The Guardian reported.
Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories.
https://people-app.onelink.me/HNIa/kz7l4cuf
A number of Latchman's friends and family members have spoken out about his death. In a post shared to Facebook on July 29, Yashley Latchman, wrote "rest in peace, my brother," alongside a photo of the two spending time in the gym together.
"You will forever be my source of inspiration and motivation," he wrote. "Thanks for everything. Will miss you loads."
Dr. Cinik clinic, located in the Besikitas area of Istanbul, has had a number of celebrity clients in the past, including former Manchester United player Rio Ferdinand, Croatian World Cup finalist Ivan Rakitić and the Brazilian World Cup winner Rivaldo (whose full name is Rivaldo Vítor Borba Ferreira).
The clinic did not immediately respond to PEOPLE's request for comment.
The facility's website states that it has performed more than 50,000 successful transplants. According to the Turkish Healthcare Travel Council, more than one million people travel to the country each year for cosmetic hair procedures.
Read the original article on People
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wall Street Journal
2 hours ago
- Wall Street Journal
All Work, No Play? There's No Virtue in That
I read Emil Barr's op-ed ''Work-Life Balance' Will Keep You Mediocre' (Aug. 19) after returning from a long weekend with family. Seventeen of us gathered to celebrate the 60th wedding anniversary of my mom and the dad who raised me. My biological father died in a car accident at age 22, six weeks before I was born. My mom remarried four years later. The stories my brothers and I heard around the dinner table were lessons about 'the best laid plans.' My son, a 30 year-old marathon runner, nearly missed the celebration. He spent 10 days in a cardiac care unit with a temporary pacemaker, the result of Lyme-induced carditis from a tick bite he never knew he had.
Associated Press
3 hours ago
- Associated Press
A Hair Transplant Journey Starting in the UK, Completed in Turkey
ISTANBUL, TURKEY / ACCESS Newswire / August 21, 2025 / Established in Turkey, Esteworld now offers face-to-face consultations in London and continues its operations in its state-of-the-art hospitals in Istanbul. This combines clinical quality with the value that has made Turkey a global destination. Post-procedure care is provided in the country where the procedure was performed. August 20, 2025 Esteworld announced the launch of a new office in London, marking the next step in the brand's international growth. Having built its reputation by delivering hair transplant in Turkey services, Esteworld is expanding access for UK and European patients who want local guidance before and after surgery, with the procedure itself performed by experienced teams in Istanbul. 'Patients told us they want two things: the clinical excellence and value associated with Turkey, and the convenience of a local touchpoint,' said an Esteworld spokesperson. 'Our London office brings those together. People can receive assessments, treatment planning, and follow-ups close to home, while their surgical journey remains anchored in our established Turkish hospitals.' A seamless UK-Turkey care pathway The London location is designed for consultations (not surgical procedures) so patients can meet a medical consultant, discuss candidacy, choose the most suitable hair transplant method, and understand the expected timeline before traveling. This model makes the experience more accessible for patients who prefer face-to-face guidance without sacrificing the standards and efficiencies that Turkey offers. A great opportunity for those who cannot have a hair transplant in London. In Istanbul, Esteworld performs procedures such as FUE (Follicular Unit Extraction), Sapphire FUE, DHI (Direct Hair Implantation), and unshaven approaches for qualifying candidates. Technique recommendations are individualized, taking into account donor density, hair caliber, curl pattern, hairline design goals, and long-term planning to maintain a natural look as hair loss progresses. About Esteworld Established in 1994, Esteworld is an international healthcare group specializing in hair transplantation, plastic surgery, medical aesthetics, and dental aesthetics. With a network spanning 35+ countries, Esteworld delivers end-to-end patient pathways through coordinated local offices and advanced hospital facilities. Esteworld's hair restoration portfolio includes FUE, Sapphire FUE, DHI, and suitable unshaven approaches, supported by standardized clinical protocols, donor management strategies, and natural hairline design principles. Multilingual patient coordination, transparent pricing structures, and comprehensive post-operative follow-up are integral to the group's service model. Combining high surgical experience with evidence-based practice and rigorous safety standards, Esteworld focuses on outcomes that look natural and remain sustainable over time. The group's integrated approach aligns medical necessity with aesthetic goals, providing patients a reliable, seamless, and internationally accessible care experience. Why Turkey remains a leader in hair transplantation Turkey's prominence in hair restoration stems from high surgical volumes, specialized teams, and a service model that streamlines logistics for international patients. Many clinics (Esteworld included also) organize airport transfers, translation assistance, and post-operative kits to reduce friction during a short medical stay. The combination of experience, coordinated care, and competitive pricing has drawn patients from around the world. About hair transplant prices in Turkey While pricing always depends on the clinic, technique, surgeon seniority, and graft count, Turkey is widely recognized for cost-effective options compared with Western Europe and North America. Patients commonly encounter two pricing structures: Because individual needs differ (some require 2,000 grafts, others 4,000 or more) final costs are best determined after a professional evaluation that considers donor capacity and long-term hair-loss patterns. Esteworld emphasizes transparent quoting so patients understand exactly what is included before traveling. What patients can expect with Esteworld Consultation & candidacy: At the London office, patients receive a structured assessment that reviews medical history, scalp condition, and donor area. The consultant discusses realistic outcomes, hairline philosophy, and potential graft counts, and sets expectations around the growth timeline. Technique selection: FUE and DHI are the most frequently recommended techniques. FUE involves extracting follicular units individually and implanting them into micro-channels; Sapphire FUE uses sapphire-tipped tools for channel creation; DHI places grafts with pen-like instruments that allow precise angle and direction. The goal is to harmonize density, direction, and hairline shape with each patient's unique features. Surgery in Istanbul: Procedures are performed by dedicated teams in Esteworld's Turkish hospitals, where standardized protocols govern anesthesia, sterile technique, graft handling, and recipient site creation. High case volumes help refine micro-surgical skills and consistency, supporting natural, age-appropriate results. Safety, ethics, and realistic expectations Hair transplantation is a medical procedure, not a commodity. Esteworld advocates for evidence-based practice and thorough informed consent. Not every patient is an ideal candidate. Donor limitations, diffuse thinning, scarring alopecia, or certain medical conditions may call for conservative plans or a staged approach. Adjunct therapies (including topical agents, oral medications when appropriate, low-level laser therapy, and PRP) may be discussed as part of a personalized long-term strategy. A natural outcome depends on more than graft numbers. Key variables include the hairline's anatomic placement, graft angulation, distribution in zones of visual priority, and respect for future hair-loss progression. Esteworld's planning process prioritizes long-term aesthetics to avoid an unnaturally dense front with inadequate reserves for later. The patient journey, step by step Value without compromise By originating in Turkey and later opening a London office, Esteworld aims to combine the best of both worlds: the experience and efficiencies that come from a leading hair transplant Turkey ecosystem, and the reassurance of local, ongoing support. For many, this hybrid model shortens decision time, clarifies expectations, and maintains continuity from first conversation to final results. 'Patients deserve clarity,' the Esteworld spokesperson added. 'Our approach is to explain the medical reasoning, set goals that make sense for the long term, and deliver attentive aftercare. Opening in London lets us do even more of that, face-to-face.' Media Details : Name: Burak Tuncer E-mail: [email protected] Phone number: +90 216 474 54 54 Web: SOURCE: Burak Tuncer press release
Yahoo
7 hours ago
- Yahoo
A Rise In Surgical Robotics Could Send These 2 Healthcare Stocks Soaring
Key Points The robotic-assisted surgery market is expected to grow significantly in the coming years. Intuitive Surgical is the leader in this space and should profit from its rapid growth. Relative newcomer Medtronic could also cash in as it launches its Hugo device. 10 stocks we like better than Intuitive Surgical › The use of robotics in surgery is on the rise. The market was valued at $800 million in 2015, and has since risen to over $3 billion. One reason behind this rapid growth is that these robot systems utilize flexible, highly maneuverable instruments along with tiny cameras, allowing surgeons to perform complex procedures, often of the minimally invasive type. Compared to open surgeries, they result in less skin cutting, less bleeding, and less scarring. However, according to one survey, while 78% of U.S. surgeons are interested in the technology, many still aren't using it, leaving significant white space ahead. The increased adoption of surgical robotics could prove to be a massive tailwind for some healthcare leaders, including Intuitive Surgical (NASDAQ: ISRG) and Medtronic (NYSE: MDT). 1. Intuitive Surgical Intuitive Surgical is currently the leader in robotic surgery, thanks to a lineup of products that includes the Ion system, which aids in performing lung biopsies, and the renowned da Vinci system, indicated for a range of procedures in general surgery and many other areas. The da Vinci system is perhaps the best-known robot device on the market. It was first approved in 2000. Intuitive Surgical has since launched several newer versions of this product; the fifth generation was introduced last year. Having a first-mover advantage will help Intuitive Surgical in at least three ways as the market expands significantly. First, the company has established a brand name among physicians, who, like everyone else, tend to gravitate toward brands they trust, especially when lives are at stake. Second, since the da Vinci system has been in use for so long, a substantial amount of data from clinical trials and real-world applications demonstrates its efficacy. That's always an advantage in the healthcare industry. Third, Intuitive Surgical has a significant existing installed base. It ended the second quarter with 10,488 installed da Vinci systems, for a 14% year-over-year increase. These are expensive devices, so healthcare facilities won't switch unless they have a very strong incentive, which grants Intuitive Surgical a strong moat thanks to high switching costs. Meanwhile, the company has routinely recorded excellent financial results: Intuitive Surgical is facing some headwinds, including increased costs resulting from tariffs. Even with those, shares should perform well over the long run as the company's products continue to gain traction in the underpenetrated and rapidly growing robotic surgery industry. Despite its underperformance in the market this year, the stock still looks like a buy today. 2. Medtronic Medtronic is inching closer to making its grand entrance in the U.S. surgical robotics industry. Earlier this year, it reported that its device, the Hugo system, had been successful in clinical trials for urologic procedures. The company is now awaiting clearance from the U.S. Food and Drug Administration in that indication. Medtronic decided to pursue this opportunity precisely because it saw massive white space. A couple of years ago, management pointed out that less than 5% of procedures that could be performed with robotic assistance actually were at the time. The company is likely to seek additional approvals for its Hugo system. While it will take some time to have a meaningful impact, Medtronic's venture into this market could be an important addition over the long run for a company that has been struggling to grow its revenue at a satisfactory rate. Medtronic has made other changes to its business recently, including deciding to spin off its only consumer-facing segment, diabetes care, whose margins were lower than those of the rest of the business. Medtronic also faces tariff-related challenges, but the decision to separate from its diabetes unit should help. Furthermore, the company consistently delivers strong financial results despite economic and other challenges. That's due to its extensive and diversified portfolio of products across several therapeutic areas, and significant presence in 150 countries worldwide. Lastly, the company has a brilliant dividend track record; having increased its payouts for 48 consecutive years, it's closing in on Dividend King status. Medtronic's stock remains a top choice for income seekers, particularly given the significant growth opportunity its launch of the Hugo system is expected to provide. Should you invest $1,000 in Intuitive Surgical right now? Before you buy stock in Intuitive Surgical, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Intuitive Surgical wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $654,781!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,076,588!* Now, it's worth noting Stock Advisor's total average return is 1,055% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025 Prosper Junior Bakiny has positions in Intuitive Surgical. The Motley Fool has positions in and recommends Intuitive Surgical. The Motley Fool recommends Medtronic and recommends the following options: long January 2026 $75 calls on Medtronic and short January 2026 $85 calls on Medtronic. The Motley Fool has a disclosure policy. A Rise In Surgical Robotics Could Send These 2 Healthcare Stocks Soaring was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
